Evidence map›Paper›PMID 18344704›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2008

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.

Angela R Bradbury, Comfort N Ibe, James J Dignam, Shelly A Cummings, Marion Verp, Melody A White, Grazia Artioli, Laura Dudlicek, Olufunmilayo I Olopade

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angela R Bradbury *University of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
Comfort N Ibe *University of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
James J DignamDepartment of Health Studies, University of Chicago, Chicago, Illinois.
Shelly A CummingsUniversity of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
Marion VerpUniversity of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
Melody A WhiteUniversity of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
Grazia ArtioliInstituto Oncologico Veneto, Padove, Italy.
Laura DudlicekUniversity of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
Olufunmilayo I OlopadeUniversity of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.

Funding

BASIC RESEARCH TRAINING IN MEDICAL ONCOLOGYT32CA009566 · NCI · UNIVERSITY OF CHICAGO · PI OLUFUNMILAYO F. OLOPADE · 1987 to 2026
$10.5M
Returning genetic research panel results for breast cancer susceptibilityR01CA190871 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRADBURY, ANGELA R. · 2014 to 2025
$6.7M
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family RegistryR01CA138819 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI BRADBURY, ANGELA R., DALY, MARY BERYL · 2011 to 2015
$3.3M
Virtual Cancer Genetic Services: Telemedicine Delivery in Community ClinicsR21CA164121 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRADBURY, ANGELA R. · 2012 to 2013
$400k
NCI NIH HHS L30 CA130130NCI NIH HHS R01 CA138819NCI NIH HHS R01 CA190871NCI NIH HHS R21 CA164121NCI NIH HHS T32 CA009566NCI NIH HHS T32 CA09566
6 · The paper itself

Abstract

purposeTo evaluate prophylactic salpingo-oophorectomy uptake and timing among BRCA1/2 mutation carriers in a cancer risk assessment program.

methodsClinical records of female BRCA1/2 mutation carriers who received cancer genetic counseling between 1996 and 2003 were reviewed to determine the completion and the timing of prophylactic salpingo-oophorectomy. Logistic regression models evaluated associations between subject characteristics and surgery. Survival analysis methods were used to estimate the distribution of time to surgery.

resultsAmong 88 women, 70% underwent prophylactic salpingo-oophorectomy. Prophylactic salpingo-oophorectomy was associated with older age, white race, having children, and a family history of ovarian cancer. Many women waited more than 12 months to undergo surgery and some delayed by several years. Younger age and not having children were associated with delays to surgery.

conclusionProphylactic salpingo-ooporectomy is an acceptable risk reduction measure for many BRCA1/2 mutation carriers. Some women make this decision many years after genetic testing. Continued discussion of the risks and benefits of risk reduction options may facilitate the uptake of recommended risk reduction interventions among BRCA mutation carriers.

Indexed as

Genes, BRCA1Genes, BRCA2MutationAdultAgedBreast NeoplasmsFallopian TubesFemaleGenetic Carrier ScreeningHumansMiddle AgedOvarian NeoplasmsOvariectomyRisk Reduction Behavior

Identifiers

PMID18344704
PMCPMC4199586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.